Sunday, January 29, 2023

Keeping You Informed

 Quote: "Pfizer, Project Veritas, and biosecurity. Just remember, since the year 2000, Pfizer has been assessed nearly $10.3 billion in penalties for criminal activities and other violations. Those 90 records include false claims, safety violations, fraud, workplace and environmental violations, foreign corrupt practices, kickbacks, and bribery. Do you trust them? I don’t.


Since the beginning of 2020, the federal government has awarded contracts to Pfizer valued at nearly $23.4 billion. $20 billion of that is for Covid-19 “vaccines” and the rest for routine adult and pediatric vaccines, medical supplies, and cancer drugs. The federal government obviously trusts Pfizer with our money and our health.

By now, tens of millions have viewed the Project Veritas video wherein Jordan Walker, Pfizer’s Director for Research & Development Strategic Operations discusses a new direction in virology research on the SARS-CoV-2 (Covid-19) virus. 


I’ll leave others to parse the veracity of all he said, including his later denials, and discuss the next steps called for by Congress and the American public.

Dr. Walker is a Yale graduate who received his MD at the University of Texas Southwestern medical school. His immediate supervisor reports to Pfizer’s CEO. Given his education, and his high rank within the company, I tend to believe he was completely accurate in describing what Pfizer has going on. The removal of his LinkedIn page (related to me by a friend) reinforces my belief.

Dr. Walker stated, “One of the things we’re exploring is like, why don’t we just mutate it [COVID] ourselves so we could create, preemptively develop new vaccines, right?” He goes on to discuss directed evolution and selected directional mutations. At one point, he appears to equate this work with gain of function research but, at another, he says it is not gain of function. What’s obvious to me is that one cannot create a vaccine until one has the infection in hand.

Here’s where concerns about biosecurity, a subset of national security, come in. SARS-associated coronavirus is identified as a Federal (HHS) Select Agent. The 2020 Federal Select Agent Program report is quite detailed about how such agents are to be registered and managed. The FSAP is a congressionally-mandated program. When Congress drills down into what’s going on, the members need to discover whether Pfizer adheres to these requirements.

Current guidance on handling and processing cultures of SARS-CoV-2 is that they should be handled in a Biosafety Level 3 (BSL-3) laboratory using BSL-3 practices and that inoculation of animals with infectious wild-type SARS-CoV-2 should be conducted in an Animal Biosafety Level 3 (ABSL-3) facility using ABSL-3 practices and respiratory protection. If Dr. Walker’s initial statements are valid, however, Pfizer plans to force the virus in primates to mutate/evolve. This doesn’t sound like wild-type SARS-CoV-2 virus.

BSL-4 laboratories are used to study infectious agents or toxins that pose a high risk of aerosol-transmitted laboratory infections and life-threatening diseases for which no vaccines or therapies are available. It’s pretty well concluded that gain of function research was being done on what ultimately became Covid-19 when it walked out of the BSL-4 laboratory In Wuhan. Millions died.

The currently approved “vaccines” do not stop the acquisition of, contagion with, transmission of, or suffering from this virus. In January 2022, the NIH asked the National Science Advisory Board for Biosecurity (NSABB) to review gain of function research. The NSABB released a draft report just a week ago that recommends more stringent biosecurity oversight of this sort of research. News-medical.net has an excellent overview here. There are nine Biosafety Level 4 facilities in the United States; none of them run by Pfizer.

Congress should have NIH and members of NSABB in to discuss updating biosafety requirements for gain of function research for SARS-associated coronaviruses. Congress should also find out if NIH or CDC knew about Pfizer’s pushing for the mutation of this genetic material in primates.

Last fall, Boston University’s National Emerging Infectious Diseases Laboratory got into a pickle over altering the SARS CoV-2 virus. At the end of the day, just a couple of weeks ago, in fact, the NIH said the experiments “were funded with private funds and were not subject to NIH review.” Weasel words, for sure, but accurate. The FSAP is managed by a division of HHS/Centers for Disease Control and Prevention (CDC), not HHS/National Institutes of Health (NIH). Congress needs to call the correct personnel to testify.

And when Pfizer says it’s not conducting gain of function research? Whether one calls it directed evolution, forced mutation, or research involving potential pandemic pathogens, it’s still categorized as gain of function. Don’t let them off the hook just because they try to redefine a well-known activity.

Insufficient biosecurity for this type of research is a threat to us all. Many more could die. Not to mention that this sounds like it’s meant to push a virus to the point where it will need a new money-making gene therapy. I’m glad to see so many in Washington calling for the facts. Not on your watch, 118th."    Pfizer, Project Veritas, and biosecurity - American Thinker


This is what happens when this Pfizer's Director Research and Development realized he had been conned.

Quote: "Pfizer executive goes thug on James O’Keefe after realizing he had been recorded boasting about ‘mutating’ Covid virus for profit. 

The incredible undercover video of a senior Pfizer executive boasting about “mutating” the Covid virus released Wednesday by Project Veritas is making waves, even though the corporate media have completely ignored it as Google suppresses searches for it. Here is the original video itself of Pfizer's Jordon Trishton Walker regaling his companion, unaware that he was being recorded.

Twitter video screengrab

And here is Tucker Carlson last night explaining the total suppression of the video despite 12 million online views and the tech oligopolists' suppression of searches for it.

Pfizer’s CEO Albert Bourla, questioned about the video by Rebel News, clammed up and dismissed the question with “Thank-you very much” and “Have a nice day.”

But new video released yesterday afternoon by Project Veritas shows Walker being confronted by Project Veritas head James O’Keefe, shown video of the encounter on an iPad, and going thug on him and others from Project Veritas, who were openly recording the encounter. The entire video is 10 minutes long, and begins with what might be called highlights, before a more complete record of the encounter. It is worth your time to watch, but in case you are in a hurry, there are some screengrabs below. (All from YouTube screengrabs)

Walker at first claims he was lying, just trying to impress a date, which is an interesting confession of sleaziness, if accurate. He also denies being a scientist, stating he was hired from a consulting firm. It will be interesting to find out which one., if this is true.

But it is when Walker tries to grab the iPad, slams it to the ground, and engages physically with PV staff that it gets interesting, and potentially criminal.

And here it goes flying to the floor:

After tussling with the PV crew, he ends up on the floor himself:

Walker instructs the owner of the café to call the police and lock the doors and prevent O’Keefe and company from leaving, which in most states constitutes kidnapping or unlawful detention. It’s odd because he is the only person potentially committing crimes. The PV crew does leave, and when they do, Walker goes outside and tries to block a car he mistakenly believes they are riding in.

When police do come and are show video of the encounter an officer states that they would arrest Walker if James O’Keefe were still present on the scene, though he had left by this time."      Pfizer executive goes thug on James O’Keefe after realizing he had been recorded boasting about ‘mutating’ Covid virus for profit - American Thinker



No comments: